Abstract

IntroductionThe benefits of non-selective ROCK1/2 inhibitors in cardioprotection are well-known, especially in the treatment of hypertension and vasospastic angina. Fasudil, (a commonly used ROCK1/2 inhibitor) reduces infarct size and no...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.